| Literature DB >> 35244073 |
Onuma Chaiwat1,2, Benjaporn Sathitkarnmanee3, Piyapat Dajpratham4, Chayanan Thanakiattiwibun2, Sunit Jarungjitaree2, Suchera Rattanamung3.
Abstract
ABSTRACT: The impact of a physical medicine and rehabilitation (PM&R) consultation on clinical outcomes in critically ill surgical patients remains unclear. The aim of this study is to examine whether the patients who received PM&R consultation will demonstrate better clinical outcomes in terms of the differences in clinical outcomes including muscle mass and strength, intensive care unit (ICU) length of stay (LOS) and functional outcomes between the PM&R consultation and no PM&R consultation and between early PM&R consultation and late PM&R consultation in critically ill surgical patients.A prospective observational cohort study was undergone in 65-year-old or older patients who were admitted > 24 hours in the surgical intensive care unit (SICU) in a tertiary care hospital. Data collection included patients' characteristic, muscle mass and muscle strength, and clinical outcomes.Ninety surgical patients were enrolled and PM&R was consulted in 37 patients (36.7%). There was no significant difference in muscle mass and function between consulted and no consulted groups. PM&R consulted group showed worse in clinical outcomes including functional outcomes at hospital discharge, longer duration of mechanical ventilation, ICU, and hospital LOS as compared with no PM&R consulted group. The median time of rehabilitation consultation was 6 days and there were no significant differences in clinical outcomes between early (≤ 6 days) and late (> 6 days) consultation.PM&R consultation did not improve muscle mass, functional outcomes at hospital discharge, and ICU LOS in critically ill surgical patients. The key to success might include the PM&R consultation with both intensified physical therapy and early start of mobilization or the rigid mobilization protocol.Entities:
Mesh:
Year: 2022 PMID: 35244073 PMCID: PMC8896451 DOI: 10.1097/MD.0000000000028990
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1Flow diagram for study patient enrollment.
Demographic data.
| Variable | Total (n = 90) | No PM&R consults (n = 57; 63.3%) | PM&R consults (n = 33; 36.7%) |
|
| Age | 75.0 ± 7.8 | 74.6 ± 7.4 | 75.7 ± 8.4 | .506 |
| Sex: male | 47 (52.2%) | 28 (49.1%) | 15 (45.5%) | .828 |
| Comorbidity diseases | ||||
| Dementia | 10 (11.1%) | 6 (10.5%) | 4 (12.1%) | 1.000 |
| Cerebrovascular disease | 5 (5.6%) | 4 (7.0%) | 1 (3.0%) | .648 |
| Diabetes mellitus | 25 (27.8%) | 16 (28.1%) | 9 (27.3%) | 1.000 |
| Hypertension | 59 (65.6%) | 36 (63.2%) | 23 (69.7%) | .647 |
| Chronic kidney disease | 19 (21.1%) | 12 (21.1%) | 7 (21.2%) | 1.000 |
| Cardiac disease | 18 (20.0%) | 11 (19.3%) | 7 (21.2%) | 1.000 |
| Cirrhosis | 3 (3.3%) | 2 (3.5%) | 1 (3.0%) | 1.000 |
| Charlson Comorbidity Index | 3 (2–4) | 3 (2–5) | 3 (2–4) | .596 |
| Smoking | 16 (17.8%) | 12 (21.1%) | 4 (12.1%) | .394 |
| Alcohol consumption | 7 (7.8%) | 5 (8.8%) | 2 (6.1%) | 1.000 |
| Statin use | 34 (37.8%) | 22 (38.6%) | 12 (36.4%) | 1.000 |
| Benzodiazepine use | 3 (3.3%) | 1 (1.8%) | 2 (6.1%) | .552 |
| APACHE-II score | 16 (11–20) | 14 (10–18) | 16 (12–20) | .106 |
| SOFA score | 5 (3–7) | 4 (3–5) | 4 (3–9) | .107 |
| Barthel index score at admission | 94.4 ± 11.9 | 94.7 ± 12.3 | 94.1 ± 11.4 | .831 |
| Barthel index score ≤ 70 at admission | 10 (11.1%) | 7 (12.3%) | 3 (9.1%) | .740 |
| FAC score | 5.0 ± 0.4 | 4.8 ± 0.5 | 5.0 ± 0.2 | .080 |
| Site of surgery | .625 | |||
| Abdomen | 41 (45.6%) | 25 (43.9%) | 16 (48.5%) | |
| Vascular | 24 (26.7%) | 14 (24.6%) | 10 (30.3%) | |
| Urologic | 12 (13.3%) | 9 (15.8%) | 3 (9.1%) | |
| Orthopedic | 4 (4.4%) | 3 (5.3%) | 1 (3.0%) | |
| Gynecologic | 1 (1.1%) | 0 | 1 (3.0%) | |
| Head and neck | 8 (8.9%) | 6 (10.5%) | 2 (6.1%) | |
| Type of surgery | .008 | |||
| Elective | 50 (55.6%) | 38 (66.7%) | 12 (36.4%) | |
| Emergency | 40 (44.4%) | 19 (33.3%) | 21 (63.6%) | |
P values for Chi-square test or Fisher exact test and independent t test or Mann–Whitney U test.
Data are presented as mean ± SD, n (%), or median (IQR).
APACHE-II score = acute physiology and chronic health evaluation ii score, FAC score = functional ambulation category score, SOFA score = sequential organ failure assessment score.
Performance of muscle mass, muscle strength, and nutrition data.
| Variable | Total (n = 90) | No PM&R consults (n = 57; 63.3%) | PM&R consults (n = 33; 36.7%) |
|
| BIVA of muscle mass (kg) | 17.4 ± 4.7 | 17.3 ± 5.0 | 17.6 ± 4.2 | .753 |
| Handgrip strength (kg) | 8.9 (0–14.6) | 8.3 (0–15.4) | 9.3 (0–14.4) | .536 |
| Quadriceps strength (kg) | 1.7 (0–2.1) | 0.8 (0–2.0) | 0 (0–2.0) | .627 |
| MRC-SS | 43.0 ± 10.3 | 44.3 ± 9.1 | 40.8 ± 11.9 | .154 |
| Different trends of muscle mass (kg) | −0.4 (−1.4–0.7) | −0.3 (−1.1–0.9) | −0.7 (−3.0–0.6) | .088 |
| Different trends of handgrip strength (kg) | −0.5 (−0.8–0.2) | 0 (−1.0–0) | 0 (0–0.5) | .096 |
| Different trends of Quadriceps strength (kg) | −0.4 (0–0) | 0 (−0.05–0) | 0 (0–0) | .604 |
| Difference of MRC-SS | −3.2 (−6–1) | −2.0 (−6.0–0) | −2.0 (−6.0–2.0) | .970 |
| SOM level | 1.0 ± 0.3 | 1.1 ± 0.2 | 1.1 ± 0.3 | .599 |
| Total calorie (kcal/kg) | 13.4 (5.0–22.2) | 8.4 (3.7–19.7) | 22.1 (13.1–23.7) | .001 |
| Total protein (g/kg) | 0.6 (0–1.1) | 0.3 (0–0.9) | 1.0 (0.5–1.1) | .001 |
P values for independent t test or Mann–Whitney U test.
Data are presented as mean ± SD, or median (IQR).
BIVA = bioelectrical impedance vector analysis, MRC-SS = medical research council sum score, SOM = SICU optimal mobilization score.
Outcome data.
| Variable | Total (n = 90) | No PM&R consults (n = 57; 63.3%) | PM&R consults (n = 33; 36.7%) |
|
| Delirium | 41 (45.6%) | 19 (33.3%) | 22 (66.7%) | .004 |
| Subtype of delirium (n = 41) | .090 | |||
| Hypoactive | 11 (26.8%) | 2 (10.5%) | 9 (40.9%) | |
| Hyperactive | 11 (26.8%) | 6 (31.6%) | 5 (22.7%) | |
| Mixed | 19 (46.3%) | 11 (57.9%) | 8 (36.4%) | |
| Duration of mechanical ventilation (days) | 7.1 (2.0–10.0) | 3.0 (1.0–4.0) | 10.0 (4.0–18.0) | <.001 |
| ICU length of stay (days) | 9.4 (3.0–14.0) | 4.0 (3.0–6.0) | 11.0 (6.0–20.0) | <.001 |
| Mortality at ICU discharge | 4 (4.4%) | 2 (3.5%) | 2 (6.1%) | .622 |
| Hospital length of stay (days) | 19.0 (14.7–34.3) | 18.0 (13.0–27.0) | 26.0 (15.0–40.0) | .006 |
| Mortality at hospital discharge | 18 (20.0%) | 10 (17.5%) | 8 (24.2%) | .585 |
| FAC score at 1 wk follow-up | 4.0 (2.0–5.0) | 4.0 (3.0–5.0) | 3.5 (1.5–4.0) | .027 |
| Barthel index ADL score at hospital discharge | 40 (5–75) | 50 (5–90) | 18 (5–48) | .036 |
| Barthel index ADL score ≤ 70 (n = 72) | 52 (72.2%) | 29 (61.7%) | 23 (92.0%) | .006 |
| Barthel index score ≤ 70 at 1 wk follow-up | 50 (25–90) | 55 (25–90) | 40 (20–78) | .125 |
| Barthel index score ≤ 70 (n = 69) | 40 (58.0%) | 24 (53.3%) | 16 (66.7%) | .317 |
P values for Chi-square test or Fisher test and Mann–Whitney U test.
Data are n (%) or median (IQR).
Barthel index ADL = barthel index of activities of daily living, FAC score = functional ambulation category score, ICU = intensive care unit.
Comparison of baseline characteristics and outcomes between early and with late PM&R consult patients.
| Factors | Total (n = 33) | Early Consult at ≤ 6 days (n = 17; 51.5%) | Late Consult at > 6 days (n = 16; 48.5%) |
|
| Age (yrs) | 75.7 ± 8.4 | 77.0 ± 6.9 | 74.3 ± 9.8 | .369 |
| Sex: male | 18 (54.5%) | 11 (64.7%) | 7 (43.8%) | .303 |
| Date of rehabilitation consultation (days) | 6 (3–12) | 3 (3–5) | 12 (9–15) | <.001 |
| Comorbid diseases | ||||
| Dementia | 4 (12.1%) | 3 (17.6%) | 1 (6.3%) | .601 |
| Cerebrovascular disease | 1 (3.0%) | 0 | 1 (6.3%) | .485 |
| Diabetes mellitus | 9 (27.3%) | 5 (29.4%) | 4 (25.0%) | 1.000 |
| Hypertension | 23 (69.7%) | 13 (76.5%) | 10 (62.5%) | .465 |
| Chronic kidney disease | 7 (21.2%) | 0 | 7 (43.8%) | .003 |
| Cardiac disease | 7 (21.2%) | 4 (23.5%) | 3 (18.8%) | 1.000 |
| Cirrhosis | 1 (3.0%) | 1 (5.9%) | 0 | 1.000 |
| Charlson comorbidity index | 3 (2–4) | 3 (2–4) | 3 (2–4) | .557 |
| APACHE-II score | 17.6 ± 8.2 | 17.7 ± 8.1 | 17.6 ± 8.5 | .994 |
| Barthel index score ≤ 70 at admission | 3 (9.1%) | 1 (5.9%) | 2 (12.5%) | .601 |
| FAC score | 5.0 ± 0.2 | 5.0 ± 0 | 4.9 ± 0.3 | .333 |
| Site of surgery | .707 | |||
| Abdomen | 16 (48.5%) | 9 (52.9%) | 7 (43.8%) | |
| Vascular | 10 (30.3%) | 4 (23.5%) | 6 (37.5%) | |
| Urologic | 3 (9.1%) | 2 (11.8%) | 1 (6.3%) | |
| Orthopedic | 1 (3.0%) | 1 (5.9%) | 0 | |
| Gynecologic | 1 (3.0%) | 0 | 1 (6.3%) | |
| Head and neck | 2 (6.1%) | 1 (5.9%) | 1 (6.3%) | |
| Type of surgery | .721 | |||
| Elective | 12 (36.4%) | 7 (41.2%) | 5 (31.3%) | |
| Emergency | 21 (63.6%) | 10 (58.8%) | 11 (68.8%) | |
| Difference of MRC-SS | −2.0 (−8.5–2.0) | −2.0 (−12.0–1.0) | −1.5 (−6.0–4.0) | .557 |
| Different trends of muscle mass (kg) | −0.7 (−3.0–0.6) | −0.1 (−3.0–0.7) | 0.7 (−2.7–−0.2) | .488 |
| Different trends of handgrip strength (kg) | 0 (−0.1–0) | 0 (−0.2–0.1) | 0 (0–1.1) | .402 |
| Different trends of quadriceps strength (kg) | 0 (0–0) | 0 (0–0) | 0 (0–0.3) | .204 |
| SOM level | 1.1 ± 0.3 | 1.1 ± 0.2 | 1.1 ± 0.3 | .524 |
| ICU length of stay (days) | 11 (6–20) | 11 (5–20) | 12 (7–24) | .763 |
| Mortality at ICU discharge | 2 (6.1%) | 1 (5.9%) | 1 (6.3%) | 1.000 |
| Hospital length of stay (days) | 26 (15–41) | 21 (15–39) | 30 (19–41) | .683 |
| Mortality at hospital discharge | 8 (24.2%) | 5 (29.4%) | 3 (18.8%) | .688 |
| FAC score at 1 wk follow-up (n = 29) | 3.5 (1.3–4.0) | 4.0 (2.0–5.0) | 3.0 (1.0–4.0) | .219 |
| Barthel index score ≤ 70 at hospital discharge (n = 25) | 23 (92.0%) | 10 (83.3%) | 13 (100%) | .220 |
| Barthel index score ≤ 70 at 1 week follow-up (n = 24) | 16 (66.7%) | 6 (50.0%) | 10 (83.3%) | .193 |
P values for Chi-square test or Fisher exact test and independent t test or Mann–Whitney U test.
Data are presented as mean ± SD, n (%) or median (IQR).
APACHE-II score = acute physiology and chronic health evaluation ii score, Barthel index ADL = barthel index of activities of daily living, BIVA = bioelectrical impedance vector analysis, FAC score = functional ambulation category score, ICU = intensive care unit, MRC-SS = medical research council sum score, SOFA score = sequential organ failure assessment score, SOM = SICU optimal mobilization score.
Figure 2Protocol for early mobilization in general surgical ICU; Siriraj hospital.